Long-Term Efficacy and Safety of Alemtuzumab in Participants with Highly Active Ms: Topaz Clinical Trial and Interim Analysis of Treat-Ms Real-World Study

AuthID
 P-018-4AA
10
Author(s)
Bass, AD
·
Van Wijmeersch, B
·
Eichau, S
·
Richter, S
·
Hoffmann, F
·
Armstrong, NM
·
Chirieac, M
·
Cunha-Santos, J
·
Singer, BA
Tipo de Documento
Article
Year published
2025
Publicado
in THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, ISSN: 1756-2856
Volume: 18
Indexing
Wos®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 39935588
Wos: WOS:001417996300001
Source Identifiers
ISSN: 1756-2856
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Citações
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2026 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service